Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients
Background: The risk of squamous cell carcinoma (SCC) is increased in solid organ transplant recipients (OTRs), and preferential treatment modalities vary among clinicians. Objectives: The purpose of this study was to survey dermatologists regarding practice patterns for electrodesiccation and curet...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | International Journal of Women's Dermatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352647519301133 |
id |
doaj-dd79b8ffe5534f67af3d735b2a93d523 |
---|---|
record_format |
Article |
spelling |
doaj-dd79b8ffe5534f67af3d735b2a93d5232020-11-25T01:29:02ZengElsevierInternational Journal of Women's Dermatology2352-64752020-03-016299101Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipientsKathleen M. Nemer, MD0Tyler M. Bauman, MD1M. Laurin Council, MD2Eva A. Hurst, MD3Division of Dermatology, Washington University School of Medicine, St. Louis, MO, United StatesDivision of Dermatology, Washington University School of Medicine, St. Louis, MO, United StatesDivision of Dermatology, Washington University School of Medicine, St. Louis, MO, United StatesCorresponding author.; Division of Dermatology, Washington University School of Medicine, St. Louis, MO, United StatesBackground: The risk of squamous cell carcinoma (SCC) is increased in solid organ transplant recipients (OTRs), and preferential treatment modalities vary among clinicians. Objectives: The purpose of this study was to survey dermatologists regarding practice patterns for electrodesiccation and curettage (EDC) of SCC in OTRs and nontransplant patients. Methods: An 18-question survey was sent to dermatologist members of the International Transplant Skin Cancer Collaborative, Association of Professors of Dermatology, and American College of Mohs Surgery. Differences in EDC practice patterns for treatment of SCC in OTRs and nontransplant patients were evaluated. Results: Dermatologists in this study (N = 227) were more likely to treat SCC with EDC in nontransplant patients (67.4%) than in OTRs (48.0%; P = .0003).Dermatologists who perform EDC in both groups (n = 108) were unlikely to use EDC on the H-zone of the face; they were more likely to EDC tumors on non-H-zone areas of the face and neck in nontransplant patients compared to OTRs (P = .0007). Dermatologists were more likely to use EDC over surgery in nontransplant patients compared to OTRs with the following demographics: dementia or psychiatric disease (P = .04), multiple medical comorbidities (P = .03), or anticoagulation medications (P = .02). Conclusions: In OTRs with SCC, 48% of clinicians would consider EDC. The main factors that affect the decision to perform EDC include tumor location and patient comorbidities. Keywords: Squamous cell carcinoma, Solid organ transplant recipient, Electrodesiccation and curettage, Survey, Practice patternshttp://www.sciencedirect.com/science/article/pii/S2352647519301133 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kathleen M. Nemer, MD Tyler M. Bauman, MD M. Laurin Council, MD Eva A. Hurst, MD |
spellingShingle |
Kathleen M. Nemer, MD Tyler M. Bauman, MD M. Laurin Council, MD Eva A. Hurst, MD Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients International Journal of Women's Dermatology |
author_facet |
Kathleen M. Nemer, MD Tyler M. Bauman, MD M. Laurin Council, MD Eva A. Hurst, MD |
author_sort |
Kathleen M. Nemer, MD |
title |
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients |
title_short |
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients |
title_full |
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients |
title_fullStr |
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients |
title_full_unstemmed |
Surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients |
title_sort |
surveyed dermatologists are less likely to curette invasive squamous cell carcinoma in solid organ transplant recipients |
publisher |
Elsevier |
series |
International Journal of Women's Dermatology |
issn |
2352-6475 |
publishDate |
2020-03-01 |
description |
Background: The risk of squamous cell carcinoma (SCC) is increased in solid organ transplant recipients (OTRs), and preferential treatment modalities vary among clinicians. Objectives: The purpose of this study was to survey dermatologists regarding practice patterns for electrodesiccation and curettage (EDC) of SCC in OTRs and nontransplant patients. Methods: An 18-question survey was sent to dermatologist members of the International Transplant Skin Cancer Collaborative, Association of Professors of Dermatology, and American College of Mohs Surgery. Differences in EDC practice patterns for treatment of SCC in OTRs and nontransplant patients were evaluated. Results: Dermatologists in this study (N = 227) were more likely to treat SCC with EDC in nontransplant patients (67.4%) than in OTRs (48.0%; P = .0003).Dermatologists who perform EDC in both groups (n = 108) were unlikely to use EDC on the H-zone of the face; they were more likely to EDC tumors on non-H-zone areas of the face and neck in nontransplant patients compared to OTRs (P = .0007). Dermatologists were more likely to use EDC over surgery in nontransplant patients compared to OTRs with the following demographics: dementia or psychiatric disease (P = .04), multiple medical comorbidities (P = .03), or anticoagulation medications (P = .02). Conclusions: In OTRs with SCC, 48% of clinicians would consider EDC. The main factors that affect the decision to perform EDC include tumor location and patient comorbidities. Keywords: Squamous cell carcinoma, Solid organ transplant recipient, Electrodesiccation and curettage, Survey, Practice patterns |
url |
http://www.sciencedirect.com/science/article/pii/S2352647519301133 |
work_keys_str_mv |
AT kathleenmnemermd surveyeddermatologistsarelesslikelytocuretteinvasivesquamouscellcarcinomainsolidorgantransplantrecipients AT tylermbaumanmd surveyeddermatologistsarelesslikelytocuretteinvasivesquamouscellcarcinomainsolidorgantransplantrecipients AT mlaurincouncilmd surveyeddermatologistsarelesslikelytocuretteinvasivesquamouscellcarcinomainsolidorgantransplantrecipients AT evaahurstmd surveyeddermatologistsarelesslikelytocuretteinvasivesquamouscellcarcinomainsolidorgantransplantrecipients |
_version_ |
1725098989137690624 |